Brazil’s Ex-President Bolsonaro Ordered To Wear Ankle Monitor: “Meant To Utterly Humiliate Me” For Trump Ties The man called among many “The Brazilian Donald Trump” or also the “Trump of the Tropics” is continuing to endure a drawn-out legal saga, to which he has newly responded, “This is meant to utterly humiliate me.” The other side […]
Trump Administration Officially Defunds CA’s High Speed Rail Authored by Kenneth Schrupp via The Center Square, The Trump administration officially terminated its funding of California’s 171-mile high speed rail segment in the state’s more sparsely populated Central Valley, citing an inability to complete the project by the 2033 deadline. The administration also noted there’s no plan for closing a $7 billion funding
Trump Administration Officially Defunds CA’s High Speed Rail Read More »
Goldman Gains “Deeper Appreciation” For Dell’s AI Servers After Investor Trip To Headquarters Dell has secured its position as a major player in the AI infrastructure space. Earlier this year, the company secured a $5 billion deal to supply advanced AI servers to Elon Musk’s xAI, powering the startup’s next-generation and ever-expanding AI compute workloads.
Trump Eyes Executive Order To Open Up Retirement Funds To Crypto; Report Authored by Stephen Katte via CoinTelegraph.com, US President Donald Trump is reportedly set to sign an executive order that could allow American 401(k) retirement plans to invest in alternative assets outside of stocks and bonds, such as cryptocurrencies. The executive order could be
Trump Eyes Executive Order To Open Up Retirement Funds To Crypto; Report Read More »
Kremlin Blasts ‘Hostile’ US Talk Of NATO Quickly Seizing Kaliningrad Russia has blasted recent comments by a top US general who boasted about NATO’s claimed ability to swiftly capture the Russian Baltic exclave of Kaliningrad if the military action is deemed necessary. Kremlin spokesman Dmitry Peskov said on Friday that “NATO is an instrument of
Kremlin Blasts ‘Hostile’ US Talk Of NATO Quickly Seizing Kaliningrad Read More »
Transparency By Molly Schwartz, Cross-Asset Macro Strategist at Rabobank Yesterday, G-20 finance ministers congregated in South Africa, though several delegates were noticeably absent, like Scott Bessent from the US. Bessent, of course, wasn’t playing hooky alone, as other truants included counterparts from Argentina, Australia, and France. That said, Bessent’s empty seat garnered special attention as
Three Dead In Explosion At Los Angeles Sheriff’s Training Facility Details are scant, but what we know so far is that three people are dead following an apparent explosion at a Los Angeles County Sheriff’s Department training facility in East Los Angeles. That large Los Angeles County facility—just east of downtown—was the site of the
Three Dead In Explosion At Los Angeles Sheriff’s Training Facility Read More »
Stephen Colbert’s “Late Show” Cancelled By CBS There is something inherently dishonest about comedians posing as political commentators. The trend, launched by Jon Stewart in 1998 when he took over The Daily Show, harnesses comedy to disarm viewers, making them more susceptible to suggestion. This isn’t such a bad thing when comedians tell the truth,
Stephen Colbert’s “Late Show” Cancelled By CBS Read More »
Bondi, Burgum Visit Alcatraz Amid Plans To Reopen It As Prison Authored by Aldgra Fredly via The Epoch Times (emphasis ours), Attorney General Pam Bondi and Interior Secretary Doug Burgum visited the former federal prison Alcatraz in California on July 17, following President Donald Trump’s order to reopen the island prison to house the nation’s
Bondi, Burgum Visit Alcatraz Amid Plans To Reopen It As Prison Read More »
Sarepta Shares Crash 25% After Third Patient Death Related Its Gene Therapy Sarepta Therapeutics has confirmed a third patient death linked to its gene therapy programs, this time involving a 51-year-old man who died in June from acute liver failure after receiving the investigational therapy SRP-9004 for limb-girdle muscular dystrophy (LGMD). The company confirmed the
Sarepta Shares Crash 25% After Third Patient Death Related Its Gene Therapy Read More »
